Pfizer (PFE) announced on Tuesday that a mid-stage trial evaluating a monthly maintenance dosing regimen of its experimental obesity drug indicated that the GLP-1 receptor agonist PF’3944 (MET-097i) ...

Breaking space news, the latest updates on rocket launches, skywatching events and more! You are now subscribed Your newsletter sign-up was successful Want to add more newsletters? Delivered daily ...

DALLAS—As pay TV operators continue to struggle with cord cutting and streaming platforms seeks to retain fickle consumers who regularly cancel subscriptions, a new study from Parks Associates takes a ...

So, you want to learn Python? That’s cool. A lot of people are getting into it these days because it’s used for all sorts of things, from building websites to analyzing data. If you’re looking for a ...

Becoming a financial risk manager is an excellent move for your career success, but it’s no walk in the park. With a pass rate that hovers between 45 and 55% for either part, you have an uphill battle ...

For people my age, there was no greater adolescent thrill than seeing your crush post “like my status for a rate” on Facebook and taking the bait. Rating and getting rated is what social media was ...

Joyce Siette receives funding from the National Health and Medical Research Council. Yet despite decades of research, major questions have remained unresolved. Does exercising at any age help reduce ...

Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN) stock is trading lower on Friday, with a session volume of 15.72 million, compared to its average volume of 1.24 million, according to Benzinga Pro. The ...

We might earn a commission if you make a purchase through one of the links. The McClatchy Commerce Content team, which is independent from our newsroom, oversees this content. This article has ...

Breakthroughs, discoveries, and DIY tips sent six days a week. Terms of Service and Privacy Policy. It’s a bird! It’s a plane! No, it’s a rat-grabbing-bat! For ...